# Study Evaluating Renal Cell Carcinoma Risk Factors

> **NCT00927043** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 145 (actual)

## Conditions studied

- Carcinoma, Renal Cell

## Interventions

- **OTHER:** Epidemiological study according to clinical practice

## Key facts

- **NCT ID:** NCT00927043
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2011-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00927043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00927043, "Study Evaluating Renal Cell Carcinoma Risk Factors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00927043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*